Sana Biotechnology, Inc. (SANA) Tops Q3 EPS by 2c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Tianci International updates Zimbabwe gold and chromium project progress